- Ocugen reported that an institutional investor exercised warrants on March 12, 2026, purchasing 10 million common shares.
- The partial warrant exercise generated gross proceeds of USD 15 million.
- Ocugen said the proceeds are expected to extend its cash runway into Q1 2027.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ocugen Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-032442), on March 20, 2026, and is solely responsible for the information contained therein.